Imaging Innovations for Placental Assessment in Response to Environmental Pollution (PARENTs) (PARENTs)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT02786420 |
Recruitment Status :
Recruiting
First Posted : June 1, 2016
Last Update Posted : February 12, 2020
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease |
---|
Placental Disease |

Study Type : | Observational |
Estimated Enrollment : | 220 participants |
Observational Model: | Cohort |
Time Perspective: | Prospective |
Official Title: | Imaging Innovations for Placental Assessment in Response to Environmental Pollution |
Actual Study Start Date : | October 2, 2015 |
Estimated Primary Completion Date : | June 2020 |
Estimated Study Completion Date : | October 2020 |

Group/Cohort |
---|
Observational
Pregnant women
|
- Ischemic Placental Disease and Environment [ Time Frame: 11 Weeks Gestational Age - Delivery ]To use multi-parametric MRI technology to assess the impact of environment pollution exposure on prediction of placental insufficiency and related outcomes (pre-eclampsia, preterm birth, and IUGR)
Biospecimen Retention: Samples With DNA

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | Female |
Accepts Healthy Volunteers: | Yes |
Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
- 18 years of age or older
- Planning to delivery at a UCLA hospital
- Carrying a viable pregnancy
- Not carrying multiple gestation
Exclusion Criteria:
- Known fetal chromosomal or structural abnormalities
- Contraindications to having MRI evaluation
- Inability to provide consent

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02786420
Contact: Sherin Devaskar, MD | 310-825-5095 | SDevaskar@mednet.ucla.edu | |
Contact: Carla Janzen, MD | 310-794-7274 | CJanzen@mednet.ucla.edu |
United States, California | |
University of California, Los Angeles | Recruiting |
Los Angeles, California, United States, 90095 | |
Contact: Sherin Devaskar, MD 310-825-5095 SDevaskar@mednet.ucla.edu | |
Contact: Carla Janzen, MD 310-794-7274 cjanzen@mednet.ucla.edu | |
Principal Investigator: Sherin Devaskar, MD | |
Principal Investigator: Carla Janzen, MD | |
Principal Investigator: Kyung Hyun Sung, Ph.D. | |
Principal Investigator: Beate Ritz, MD |
Principal Investigator: | Sherin Devaskar, MD | University of California, Los Angeles |
Responsible Party: | Sherin Devaskar, Distinguished Professor of Pediatrics, Mattel Executive Endowed Chair, Department of Pediatrics, Executive Director, UCLA Children's Discovery and Innovation Institute, University of California, Los Angeles |
ClinicalTrials.gov Identifier: | NCT02786420 |
Other Study ID Numbers: |
15-001388 |
First Posted: | June 1, 2016 Key Record Dates |
Last Update Posted: | February 12, 2020 |
Last Verified: | February 2020 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | No |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
pregnancy magnetic resonance imaging environmental air pollutants |
Placenta Diseases Pregnancy Complications |